Vox Sanguinis

Article	Citations
Issue Information	28
	24
Events	19
Evaluation of bleed duration and adverse donor reactions during the blood donation process	19
Basophil activation test for allergic and febrile non‐haemolytic transfusion reactions among paediatric patients with haematological or oncological disease	19
Cord blood freezing bag breakage at transplant centres: Low breakage rate in Japan	19
The prototypical UK blood donor, homophily and blood donation: Blood donors are like you, not me	16
Issue Information	16
West Nile and Usutu viruses are efficiently inactivated in platelet concentrates by UVC light using the THERAFLEX UV‐Platelets system	16
Issue Information	15
Anti‐monkeypox virus‐neutralizing activities of human immunoglobulin manufactured between 1999 and 2021 and derived from donors in the United States and Japan	14
A positive blood culture is associated with a lower haemoglobin increment in hospitalized patients after red blood cell transfusion	14
Transfusion‐associated acute lung injury following albumin treatment in liver disease	14
A novel syphilis Treponema pallidum lipoprotein peptide antigen diagnostic assay using red cell kodecytes in routine blood centre column agglutination testing platforms	13
Examining prosocial tendencies in men who have sex with men: Potential impacts on blood donation following the 2023 reform	12
Issue Information	12
Risk of a blood donation contaminated with hepatitis E virus entering the blood supply before the implementation of universal RNA screening in France	11
Supplying whole blood with drones for prehospital transfusion at trauma sites in Finland: A simulation	11
Integrated serological and molecular investigation of ABO subgroups underlying atypical ABO typing	11
Removing hepatitis C antibody testing for Australian blood donations: A cost‐effectiveness analysis	11
Quality assessment and harmonization of laboratories across Europe for multiple SARS‐CoV‐2 serology assays	11
Anti‐D prophylaxis should protect all newborns from haemolytic disease, regardless of their country of residence	11
Issue Information	10
Investigating human platelet antigens and antibodies in pregnancy: An 11‐year experience from a Canadian reference laboratory	10
Bacterial proliferation is comparable in red blood cell concentrates stored in DEHT / PAGGSM and	10

RhD mismatch does not affect haematopoietic recovery, graft‐versus‐host disease and survival in allogeneic haematopoietic cell transplantation: A Japanese registry‐based study	10
The efficacy of interactive communication interventions for motivating blood donation: A systematic review	10
Events	9
Corrigendum	9
Notification of blood donors who test positive for transfusion‐transmissible infections	9
Harnessing big data and artificial intelligence in transfusion medicine: Opportunities for precision, safety and efficiency	9
Evidence that CD36 is expressed on red blood cells and constitutes a novel blood group system of clinical importance	9
	9
Events	9
Non‐neutralizing antibody profiles against hepatitis B virus: A comparative study of Japanese‐ and US‐donor‐derived intramuscular human hepatitis B‐specific immunoglobulin preparations	9
	9
Issue Information	9
Voluntary blood donation preferences in China: A discrete choice experiment among experienced and inexperienced donors	9
Events	8
Virtual platelet cross‐matching as transfusion management for patients with immune platelet refractoriness	8
Parents' perception and knowledge regarding blood transfusion in a tertiary care paediatric centre in India	8
Real‐world performance of a clinical droplet digital polymerase chain reaction assay for non‐invasive foetal blood group and platelet antigen genotyping of alloimmunized pregnant women with antibodies	8
Evaluation of immunoglobulin replacement therapy in secondary immunodeficiency at three British Columbia hospitals	8
	8
Development of an in‐house bone marrow collection kit: The Catalan bone marrow transplantation group experience	8
Pre‐donation deferral rates and causes among whole blood and apheresis platelet donors in China: A multi‐centre retrospective study (2016–2024)	8
Re‐evaluating treatment thresholds in patient blood management: Female patients experience more perioperative anaemia and higher transfusion rates in major elective surgery	8
Research partnerships between blood services and public health authorities: An international, cross‐sectional survey	8
Has the switch to sexual risk behaviour screening impacted deferrals for pre‐ and post‐exposure prophylaxis therapy for human immunodeficiency virus?	8
Plasma transfusion practices: A multicentre electronic audit	8
Deferral of blood donors who have ever stayed in a Trypanosoma cruzi endemic area: An international survey	8
Impact of conflict/war disasters on blood banks and transfusion services in low‐ and middle‐income countries in the Eastern Mediterranean region	8
Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low‐ and middle‐income countries	8
	8
In vitro quality assessment of red blood cells and plasma units in DEHT / SAGM bags and	8
Blood transfusion dynamics in Colombia: Unveiling patterns, reactions and survival rates in multitransfused patients	8
Events	7
Characterization of transfusion‐relevant bacteria reference strains in a lyophilized format	7
Securing commitment and control for the supply of plasma derivatives for public health systems. I: A short review of the global landscape	7
Identification of a novel variant c.761C>T onABO*B.01gene in ABO glycosyltransferases associated with Bweakphenotype	7
Events	7
Iron recovery dynamics after whole blood donation and the effect of low‐dose iron supplementation in Japanese donors	7
Proof of concept for detection of staphylococcal enterotoxins in platelet concentrates as a novel safety mitigation strategy	7
International Forum on Transfusion Education for Healthcare Professionals Who Administer Blood to Patients in Hospitals and Health Services: Summary	7
Successful implementation of a patient blood management programme in a lower middle‐income state	7
Author Index	7
Laboratory approach for vaccine‐induced thrombotic thrombocytopenia diagnosis in the Netherlands	7
Transforming transfusion safety: Insights from implementing bedside electronic checks at a large UK National Health Service trust	7
The role of CD36 antibodies in haematopoietic stem cell transplantation	7
End of selection criteria based on sexual orientation: An international symposium on alternatives to donation deferral	7
Demographics and donor motivation drive declining blood donations: A 15‐year study in Germany reflecting trends in high‐income countries	7
Issue Information	7
A norm for all seasons: Application of the ISO 14001 standard to manage the environmental impacts of transfusion	7
Standardized electronic messages to enhance communication in transfusion and transplantation	6
Advancing resilience and sustainability in plasma collections and plasma‐derived medicinal product accessibility	6

Is it time for the death knell of single‐unit plasma?	6
Can volume‐reduced plasma products prevent transfusion‐associated circulatory overload in a two‐hit animal model?	6
Risk of variant Creutzfeldt–Jakob disease in a simulated cohort of Canadian blood donors	6
Efficacy of intravenous immunoglobulin following plasma exchange in the management of ABO haemolytic disease of the newborn	6
Pathogen reduction with methylene blue does not have an impact on the clinical effectiveness of COVID‐19 convalescent plasma	6
	6
Dengue, chikungunya and Zika virus surveillance in blood donors in Brazil , 2019–2021	6
In vitro comparison of cold‐stored whole blood and reconstituted whole blood	6
Ethnic diversity in Chilean blood groups: A comprehensive analysis of genotypes, phenotypes, alleles and the immunogenic potential of antigens in northern, southern and central regions	6
Beyond transfusion: Platelet‐derived therapeutic products as a new frontier for blood establishments and transfusion medicine	6
International Forum on Genotyping of Blood Antigens in Donors: Summary	6
Comment on ‘Frederic Duran‐Jordà: 120th anniversary of the birth of a transfusion pioneer’	6
Fundamentals of big data and artificial intelligence in transfusion medicine	6
Characteristics of red blood cell transfusion among very preterm infants in China	6
Screening, genotyping and haematological analysis of glucose‐6‐phosphate dehydrogenase deficiency in the blood donors of Wuxi City, China	6
Tetanus antibodies in normal human immunoglobulin preparations	6
Assessment of amino acids and metabolites in the supernatant of stored concentrates blood from sickle cell trait (SCT) and reference (non‐SCT) donors	6
Identification of breakpoint regions and single nucleotide variations of RHD hybrid alleles by long‐read sequencing	6
Use of O RhD‐negative red blood cells: A nationwide, prospective audit	6
Molecular biology analysis of ABO blood group variants caused by natural chimaerism	6
Analysis of maternal Fc gamma receptor IIIb isoantibodies using immunomagnetic negative selected neutrophils	6
The association between attitude towards facemasks, quality of donation experience and relationship with healthcare providers: A cross‐sectional exploratory study	6
Alemtuzumab and autoimmune haemolytic anaemia: Coincidence or causation?	6
Age, CD34+ cell dose, conditioning and pre‐transplant cytopenias can help predict transfusion support in lymphoma patients undergoing autologous stem cell transplantation	6
Events	6
Coagulation assay results at birth in preterm infants: A cohort study highlighting the relevance of local reference values for interpretation	6
Human immunodeficiency virus, hepatitis C virus and hepatitis B virus incidence in blood donors from 2000 to 2020 in France: Trends and lessons from haemovigilance surveillance	6
Closed system production of serum eye drops using dockable saline	6
Evaluating alloimmunization risk in patients with sickle cell disease and in prenatal care patients with RHCE	6
Evaluation of a method to fluorescently label platelets for in‐human recovery and survival studies	6
Events	6
Evaluation of cell collection efficiency in non‐mobilized adult donors for autologous chimeric antigen receptor T‐cell manufacturing	5
The contemporary management of haemolytic disease of the fetus and newborn	5
Current state of gene therapy in sickle cell disease	5
	5
Analysis of gender representation on transfusion medicine journal editorial boards: Comparison between 2019 and 2022	5
Response of the Japanese Red Cross Blood Center in Ishikawa Prefecture to the 2024 Noto Peninsula earthquake	5
Events	5
Issue Information	5
Determination of IgG1 and IgG3 subclasses of red blood cell antibodies: An important tool for pred	5
Issue Information	5
	5
	5
	5
Irregular antibodies in paediatric haematological disorders: Prevalence and characteristics from a Vietnamese tertiary centre	5
Multinational transfusion practices and outcomes in haematology patients admitted to the intensive care unit	5
Meteorological elements associated with vasovagal reactions in blood donors: Influence of collection setting and donation type	5
Diary of Events	5
International Society for Blood Transfusion Guidelines for Validation of Automated Systems in Blood Establishments	5
The impact of non‐disclosure of HIV status and antiretroviral therapy on HIV recency testing and incidence algorithms	5
Events	5
A para‐Bombay phenotype due to compound heterozygosity involving a novel FUT1 variant	4
Organizational monitoring of patient blood management implementation: Results of an Italian national survey	4
Use of preoperative erythropoietin‐stimulating agents is associated with decreased thrombotic adverse events compared to red blood cell transfusion in surgical patients with anaemia	4
Author Index	4
Frequency of human platelet antigens (HPA) in the Greek population as deduced from the first registry of HPA‐typed blood donors	4
Development and validation of a scoring system to predict vasovagal reaction upon whole‐blood donation	4
Incentives for plasma donation	4
Onsite vasovagal reactions with and without loss of consciousness are distinct outcomes with different risk factors	4
Transfusion‐related acute lung injury induced by human leucocyte antigen‐II antibodies: Analysis of antibody typing and source	4
Issue Information	4
Challenges in promoting stewardship of albumin: A comparative perspective from recent guidelines	4
Issue Information	4
Association between NT‐proBNP and false‐positive Coombs test in patients with heart failure and elevated NT‐proBNP	4
Does high body mass index (>25 kg/m2) or weight (>80 kg) reduce the effectiveness of anti‐D prophylaxis in Rh(D)‐negative pregnant women? A systematic review and meta‐analysis	4
Hepatitis B virus genotype surveillance in Canadian blood donors and a referred patient population, 2016–2021	4
Enhanced O 2 availability in platelet concentrates stored for neonatal t	4
Associated criteria used in investigating suspected septic transfusion reactions: A scoping review	4
Events	4
Impact of donor ferritin testing on iron deficiency prevention and blood availability in France: A cohort simulation study	4
The evolution and interpretation of seroprevalence of SARS‐CoV‐2 antibodies among South African blood donors from the Beta to Omicron variant‐driven waves	4
A scoping review of grey zone use for transfusion‐transmitted infection screening among blood donors	4
Transfusion efficacy of leucoreduced packed red blood cells prepared by two different methods: A randomized controlled trial in transfusion‐dependent thalassaemia patients (FUEL trial)	4
Clinical transfusion practice in Ethiopia	4
Prediction of blood volume to be processed to achieve a target number of CD34+ cells: Development, validation and implementation of a formula	4
The availability of plasma donors and plasma: A sociologist's perspective	4
Meta‐analysis of efficacy and safety of pathogen‐reduced platelet components: Request for clarification	4
Issue Information	4
Issue Information	4
Analysis of wrong blood in tube events at a hospital‐based blood centre in a tertiary care referral hospital: A perspective from a lower middle‐income country	4

The effect of near‐infrared low‐level light on the in vitro quality of platelets during storage	4
The safety of pathogen‐reduced platelet transfusions in critically ill term and preterm neonates	4
Donors in the COVID‐19 era: How did donor characteristics change in Japan?	4
Paediatric clinical decision support: Evaluation of a best practice alert for red blood cell transfusion	3
Eye drops of human origin—Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies	3
Safeguarding plasma for fractionation: How can we deal with operational challenges in European Union countries	3
Detecting serologically difficult ABO blood groups using single‐molecule real‐time sequencing technology	3
Effects of plasmapheresis frequency on health status and exercise performance in men: A randomized controlled trial	3
	3
Expansion strategies for umbilical cord blood haematopoietic stem cells in vitro	3
Blood transfusion is associated with increased mortality for neonates with congenital diaphragmatic hernia on extracorporeal membrane oxygenation support	3
Issue Information	3
Comment on ‘Comparing specificity and seroconversion sensitivity among major blood screening assays for human immunodeficiency virus and viral hepatitis’	3
Response to comments from the International Patient Organization for Primary Immunodeficiencies on ‘Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low‐ and middle‐i	3
Issue Information	3
Hepatitis E virus seropositivity in an ethnically diverse community blood donor population	3
Issue Information	3
Influence of donor age, sex and ethnicity on high‐titre anti‐A and ‐B: Review of 6 million donations from two national blood providers	3
Using competition for plasma donor recruitment and retention: An Australian university case study	3
	3
Issue Information	3
The importance of confirmatory assays in testing blood donors for human T‐cell lymphotropic virus	3
HLA Class II regulation of immune response in sickle cell disease patients: Susceptibility to red blood cell alloimmunization (systematic review and meta‐analysis)	3
Autoantibodies to ADAMTS13 in human immunodeficiency virus‐associated thrombotic thrombocytopenic purpura	3
False‐positive infectious screening results among blood donors	3
Blood collection technique and processing impact the nucleosomes and complement contents of platelet products	3
Can reactive donor screening results be presumed false positive following unstandardized testing procedures?	3
Determination of CD177 (human neutrophil antigen 2) polymorphisms using nanopore sequencing	3
Therapeutic efficacy and safety of pathogen‐reduced platelet components: Results of a meta‐analysis of randomized controlled trials	3
Facilitators of and barriers to blood donation among voluntary non‐remunerated blood donors in sub‐Saharan Africa: A scoping review	3
	3
Explainable haemoglobin deferral predictions using machine learning models: Interpretation and consequences for the blood supply	3
Contemporary patient blood management in abnormally invasive placenta at a tertiary centre, with a focus on the role of the transfusion practitioner	3
Transfusion consent in Brazil: A nationwide survey of practices and form content	3
Prevalence and diagnostic accuracy of syphilis screening in blood donors: A prospective observational study comparing three different serological platforms	3
International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology Report of Basel and three virtual business meetings: Update on blood group systems	3
The value of genetic data from 665,460 individuals in managing iron deficiency anaemia and suitability to donate blood	3
Bacterial screening of platelet components: Experience at a hospital‐based blood bank	3
Split red blood cell units contain defined extracellular K + levels, which are improved by a washing procedure	3
Managing the risk of transfusion‐transmitted malaria from Australian blood donations: Recommendation of a new screening strategy	3
Paris Olympics and Paralympics: Insights from nationwide coordination in preparedness, supply chain management and blood inventory	3
Use of selective phenotyping and genotyping to identify rare blood donors in Canada	3
A retrospective analysis of postpartum red blood cell transfusions at a tertiary care obstetric centre	3
Simulated effects of ferritin screening on C‐reactive protein levels in recruited blood donors	3
A congress report of the new Emerging Pathogens and Parasitology Subgroup within the ISBT Working Party on Transfusion‐Transmitted Infectious Disease	3
A comprehensive approach to continuous quality improvement of massive transfusion by developing key performance indicators	3
The selection and preparation of red cell components for intrauterine transfusion: A national survey	3
Long‐term forecasting of blood donations using time series of donation activity: Findings from seven blood establishments	3
Factors influencing transfusion reactions in paediatric patients: Active haemovigilance data from a children's hospital in India	3
Cryopreserved platelets washed with a dialysis machine for dimethyl sulphoxide removal	3
Prevalence of adsorbed A antigen onto donor‐derived group O red cells in children following stem cell transplantation: A single‐centre evaluation	3
Vaccination and transfusion safety at the time of expanding use of live attenuated vaccines	3
Extending the post‐thaw shelf‐life of cryoprecipitate when stored at refrigerated temperatures	3
Issue Information	3
Using unmanned aerial vehicles (drones) to improve access to blood in low‐ and middle‐income countries: Current challenges and opportunities	3
Three buffy coat platelet concentrates: Use of data modelling to make more with less	3
Validation of a flow‐cytometry‐based red blood cell antigen phenotyping method	3
Cost‐effectiveness of cEK ‐preventive matched transfusion strategies for female transfusion recipients to prevent haemolytic disease of the foetus an	3
Protection of fundamental human rights by improving patient access to plasma‐derived therapies and donor health protection	3
Prophylactic high‐dose granulocyte transfusions following allogeneic haematopoietic stem cell transplantation	3
Issue Information	3
A questionnaire‐based survey on conversion from whole blood to apheresis donations among group AB donors in Hong Kong	3
Raising the single‐unit transfusion benchmark in a national quality improvement campaign: Can we do better?	3
Diary of Events	3
Optimization of the antibody identification interval in a high‐volume transfusion centre	3
Platelets retain function and can be stored following disruption of human leucocyte antigens	3
Is dual testing for hepatitis C necessary? Modelling the risk of removing hepatitis C antibody testing for Australian blood donations	3
Management of blood transfusion services in low‐resource countries	3
Comparison of automated versus semi‐automated whole blood processing systems: A systematic review	3
Monitoring viral genomic sequences in transfusion‐transmitted viruses	3
International Forum on Management of Blood Donors with Culture‐Positive Platelet Donations: Responses	3